Ireland· IE-PA-EU/1/13/901/003
SIRTURO 20 mg tablets
A bedaquiline product containing bedaquiline fumarate, registered in Ireland by Janssen-Cilag International NV. The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Bedaquiline is registered in 13 of 19 countries.
Countries holding a registration under ATC J04AK05 (bedaquiline), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Bedaquiline · ATC J04AK05
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Bedaquiline fumarate
- Manufacturer
- Janssen-Cilag International NV
- Country
- Ireland (IE)
- ATC code
- J04AK05
- ATC class
- Bedaquiline
- Defined daily dose
- 86 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/13/901/003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
325 interactions on record for bedaquiline.
Graded by severity as the source publishes them — 141 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bedaquiline · interactions on record
325 records
- 141 severe
- 182 moderate
- 2 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bedaquiline in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSIRTUROJanssen-Cilag International N.V., Beerse
- FinlandSIRTUROJanssen-Cilag International NV
- United KingdomSirturo 20mg tabletsJanssen-Cilag Ltd
- IcelandSIRTUROJanssen-Cilag International NV*
- NetherlandsSirturo 20 mg, tabletJanssen-Cilag International NV
- PolandSirturoJanssen-Cilag International N.V.
- SwedenSIRTURO 20 mg TablettJanssen-Cilag International NV
- United StatesSIRTUROJanssen Products, LP
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Sirturo
- Liechtenstein · Sirturo
- Norway · Sirturo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a4eb3add-ee21-48cf-be73-cd912e421e99 GET /v1/drugs/a4eb3add-ee21-48cf-be73-cd912e421e99?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"J04AK05"
],
"strength": null,
"pa_number": "EU/1/13/901/003",
"substances": [
"Bedaquiline fumarate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "26/03/2021",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about bedaquiline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.